Ultrasonographic Evaluation of the Effectiveness of Different Techniques
Launched by SELCUK UNIVERSITY · Jun 8, 2022
Trial Information
Current as of July 06, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of mild to moderate carpal tunnel syndrome on electrodiagnostic examination
- • Being between 20-55 years old
- • Volunteering to participate in the treatment to be given
- Exclusion Criteria:
- • Have a systemic inflammatory disease
- • Having any disease that may cause polyneuropathy, such as diabetes mellitus
- • Cognitive impairment
- • Receiving psychotherapy
- • Having a pacemaker
- • illiterate
- • Having a disease affecting the central nervous system
- • Having a hearing problem
- • Any skin disease that would contraindicate manual lymphatic drainage
- • Arterial or venous circulatory disorders that would contraindicate manual lymphatic drainage
- • NSAID drug use
About Selcuk University
Selçuk University is a prominent educational institution located in Turkey, recognized for its commitment to advancing medical research and clinical studies. As a clinical trial sponsor, Selçuk University leverages its extensive academic resources and expertise to conduct innovative research that aims to address significant healthcare challenges. The university fosters collaboration among researchers, healthcare professionals, and industry partners to facilitate the development of new therapies and improve patient outcomes. Through rigorous adherence to ethical standards and regulatory guidelines, Selçuk University strives to contribute to scientific knowledge and enhance the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kütahya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials